The FDA has approved a new, voice guided epinephrine auto-injector for emergency use to counter the effects of anaphylaxis.
Sanofi announced approval for the Auvi-Q device in a press release from their Paris headquarters on August 13, 2012. The device is roughly credit card size and fits easily in a pocket or purse. Activating the device by pulling off the cap initiates a voice recording that steps the user through the procedure.
Here is a video provided by Sanofi demonstrating the Auvi-Q’s use:
The step-by-step voice prompts make this device ideal for use by care-givers, teachers, school nurses and babysitters.
Looks interesting. I’m wondering how long the battery life is available for these? Worth looking into for sure.
I can’t say for sure but I would expect the prescription to age out well before the battery.
One of our Facebook readers wrote in to tell us that the Auvi-Q will be available to US consumers in November 2012.